Skip to content

MiMedx Group MDXG Balance Sheet Statement

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
$159.77M+50.1%$166.12M+59.1%$142.08M+60.0%$118.87M+72.2%$106.43M+120%
$296.76M+24.7%$307.35M+32.4%$281.9M+22.5%$255.09M+13.4%$237.99M+8.2%
$26.23M+9.0%$25.34M+6.4%$26.5M+9.3%$24.89M-0.7%$24.07M-1.6%
$240.33M+20.1%$277.47M+44.6%$254.1M+47.6%$220.88M+43.4%$200.11M+44.1%
$4.76M-17.6%$4.71M-20.7%$5M-22.4%$5.39M-21.0%$5.77M-21.3%
$19.44M0.0%$19.44M0.0%$19.44M0.0%$19.44M0.0%$19.44M0.0%
$12.03M+22.5%$13.12M+12.8%$10.06M+3.7%$10.95M+8.9%$9.82M-6.9%
$308.68M+14.1%$342.65M+29.8%$318.99M+30.8%$291.11M+26.5%$270.42M+22.0%
$11.46M+29.3%$14.53M+96.1%$11.42M+64.9%$8.5M+11.8%$8.87M-8.5%
$1.5M+33.3%$1.5M+50.0%$1.38M+37.5%$1.25M+25.0%$1.13M+12.5%
$44.55M+4.5%$64.27M+40.9%$57.68M+37.5%$50.29M+25.7%$42.62M+0.9%
$16.09M-8.2%$16.47M-7.6%$16.84M-6.5%$17.21M-5.7%$17.53M-5.0%
$65.74M-2.8%$86.11M+21.6%$80.04M+27.3%$74.49M+19.9%$67.64M+2.6%
250M0.0%250M+169,968%250M0.0%250M0.0%250M0.0%
-$53.54M+36.4%-$42.68M+53.2%-$57.87M+41.4%-$74.62M+30.1%-$84.24M+32.3%
$242.94M+19.8%$256.55M+32.9%$238.95M+32.0%$216.62M+28.9%$202.78M+30.2%
$308.68M+14.1%$342.65M+29.8%$318.99M+30.8%$291.11M+26.5%$270.42M+22.0%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are MiMedx Group's total assets?
MiMedx Group (MDXG) holds $308.7M in total assets, up 14.1% year over year.
How much debt does MiMedx Group have?
MiMedx Group carries $17.6M in total debt against $242.9M of shareholders' equity, a debt-to-equity ratio of 0.07.
How much cash does MiMedx Group have?
MiMedx Group holds $159.8M in cash and equivalents.
Can MiMedx Group cover its short-term obligations?
Its current ratio is 5.39 — current assets exceed current liabilities.
Where does MiMedx Group's balance sheet data come from?
Every line is extracted from MiMedx Group's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.